Who Owns the Cardiovascular-Kidney-Metabolic Patient Before the Event Occurs?

Chronic Kidney Disease (CKD) associated with Type 2 Diabetes (T2D) continues to be a major contributor to cardiovascular morbidity, kidney failure, and premature mortality worldwide. As the understanding of the interconnected Cardiovascular-Kidney-Metabolic (CKM) continuum continues to evolve, healthcare professionals must adopt a proactive, multidisciplinary, and evidence-based approach to identifying and managing patients before irreversible complications occur.

"Who Owns the Cardiovascular-Kidney-Metabolic Patient Before the Event Occurs?" is a high-impact virtual Continuing Professional Development (CPD) training designed to provide healthcare professionals with the latest clinical evidence, practical treatment strategies, and expert insights into the prevention and management of CKD associated with T2D. The programme will explore the underlying mechanisms driving disease progression—including hemodynamic, metabolic, inflammatory, and fibrotic pathways—and discuss emerging therapeutic approaches, including the role of Finerenone in improving patient outcomes.

Facilitated by distinguished clinicians and subject matter experts with extensive experience in cardiovascular, renal, metabolic and diabetes care, this highly interactive session combines expert presentations, real-world clinical perspectives, and a dynamic expert panel discussion that will allow participants to engage directly with leading specialists.

Whether you are involved in primary care, specialist practice, hospital medicine, pharmacy, nursing, or any discipline involved in the care of patients with diabetes, kidney disease, or cardiovascular conditions, this event promises practical knowledge that can immediately enhance clinical practice.

WHY YOU SHOULD ATTEND

This programme has been carefully designed to deliver practical, evidence-based knowledge that can be applied immediately in clinical practice.

By attending, you will:

1. Gain the latest evidence on CKD associated with Type 2 Diabetes and the evolving CKM approach to patient care.

 2. Learn directly from highly experienced clinicians and experts in cardiovascular, renal, metabolic and diabetes medicine.

3. Understand the scientific rationale and clinical evidence supporting newer treatment strategies, including Finerenone. 

 4. Develop practical skills for identifying suitable patients and implementing evidence-based interventions early.

 5. Participate in a highly interactive learning experience with opportunities to ask questions and discuss real-world clinical challenges.

 6. Earn accredited CPD points from the relevant professional regulatory bodies.

 7. Network virtually with colleagues and experts across multiple healthcare disciplines.

cardiovascular and kidney complications before major clinical events occur.

TOPICS TO BE PRESENTED

The programme will include presentations on:

i. Current Standards of Care in CKD: Optimizing Patient Outcomes

 ii. Clinical Role of Finerenone

 iii. Practical Considerations for Patient Selection

 iv. Future Directions in Chronic Kidney Disease Management

 v. The Cardiovascular-Kidney-Metabolic (CKM) Approach to Early Patient Care

 vi. Expert Panel Discussion and Interactive Question & Answer Session

EVENT HIGHLIGHTS

Participants can look forward to:

1. Expert-led presentations by highly experienced clinicians

 2. Latest evidence-based updates in CKD and CKM management

 3. Practical clinical guidance applicable to everyday practice

 4. Comprehensive review of landmark Finerenone clinical trials

 5. Interactive discussions with opportunities to ask questions

 6. Expert Panel Discussion featuring experienced specialists

 7. Real-world clinical insights and case-based learning

 8. Accredited CPD points upon successful participation

 9. Fully virtual participation from any location

PROUDLY SPONSORED BY

This is a hybrid event. The CPD event will be streamed LIVE on this page.

Moderator: Dr. Yacoba Atiase

Date:  Thurs. 23rd July, 2026

Time: 1500 GMT (3:00pm local time)

Target Audience: Medical Doctors & Pharmacists

In-person attendance at the Accra City Hotel, Accra.

Don’t miss out on this exciting opportunity to elevate your skills and make a lasting impact!

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for "Who Owns the Cardiovascular-Kidney-Metabolic Patient Before the Event Occurs?", you consent to participate in this training hosted by Continuous Education Services (CES) on behalf of Bayer Pharmaceutical and DP World.

Your registration information will be used solely to facilitate your participation in the training and to process Continuing Professional Development (CPD) accreditation with the Medical and Dental Council (MDC) and the Pharmacy Council, where applicable.

CES is committed to protecting your privacy and maintaining the confidentiality of your personal information. Your personal data will not be shared with Bayer Pharmaceutical or DP World. Information collected during registration will only be disclosed to the relevant professional regulatory authorities for the exclusive purpose of awarding CPD points earned through participation in this programme.

Participation in this event is entirely voluntary. You are free to leave the virtual meeting at any time without any further obligation. CES remains committed to handling all participant information securely, responsibly, and in accordance with applicable data protection and privacy principles.